329. 無虹彩症 Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 5 / 薬物数 : 6 - (DrugBank : 2) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Ataluren
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States
Blood specimen
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
Conjunctival impression
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan
Peripheral venous blood sample
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Questionnaire
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States
Blood specimen
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
Conjunctival impression
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan
Peripheral venous blood sample
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Questionnaire
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
